Due to its powerful ability to deplete cholesterol from the plasma membrane of cells, methyl-β-cyclodextrin (MβCD) has been widely used as a putative research tool in cell biology. Recently, recruiting MβCD as an effective drug (e.g., antitumor drugs) has been developed. However, it remains unclear whether MβCD, when it enters the blood circulation as a drug, influences the functions of the endothelium, e.g., the adhesion of leukocytes to the endothelium. In this study, we found that MβCD can impair the adhesion of monocytes to the monolayer of endothelial cells by lowering the cell-surface adhesive force and expression of adhesion molecules and caveolae-related molecules on/in endothelial cells, and reorganizing the actin cytoskeleton of endothelial cells. The data imply that MβCD, when recruited as a drug, potentially helps to inhibit inflammation or initiation/progression of atherosclerosis since its important early step is the adhesion of circulating leukocytes (e.g., monocytes) to the endothelium.Key words methyl-β-cyclodextrin; monocyte; endothelial cell; adhesion molecule; caveola; actin cytoskeleton Beta-cyclodextrin (β-CD) is a cyclic oligosaccharide consisting of seven α-(1,4)-linked glucopyranose subunits. Due to its relatively low water solubility (approximately 2% weight by weight), 1) various derivatives of β-CD have been developed to significantly improve the water solubility, among which methyl-β-cyclodextrin (MβCD) is the one studied most intensively. MβCD is well known as a putative powerful cholesterol-depleting agent and commonly used to deplete plasma membrane cholesterol from cultured mammalian cells.
2-4)MβCD-cholesterol complexes also can efficiently replenish cells with cholesterol as cholesterol donors. 3,4) Moreover, due to the structure of a lipophilic internal cavity surrounded by hydrophilic outer surface, MβCD was applied as a drug delivery system. 5) Recently, it was found that MβCD per se potentially has antitumor effects and has the possibility of being an effective antitumor drug.6-11) However, it remains uncertain whether MβCD, as an anticancer drug, influences the functions of the endothelium, e.g. the adhesion of circulating leukocytes (e.g. monocytes) onto the endothelium which is an important step during inflammation or initiation/progression of atherosclerosis.In this study, the effect of MβCD on the adhesion of monocytes onto the monolayer of endothelial cells was first evaluated. Then, the effects of MβCD on cell-surface adhesive force properties, expression/distribution of adhesion molecules and caveolae-related molecules, and actin cytoskeleton of endothelial cells were investigated to elucidate the potential underlying mechanisms.
MATERIALS AND METHODSCell Culture Human umbilical vein endothelial cells (HUVECs) were purchased from Xiangya Central Experiment Laboratory (Hunan, China) and cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco, U.S.A.) supplemented with 10% (w/v) fetal calf serum (Hyclone, South Logan, UT, U.S.A), 100 U/mL penicillin, and 100 µg/m...